EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial

N Mohy iD, S Sanaie iD, S Rahnemayan iD, M Yousefi iD, M Talebi iD, A Naseri iD

Beneficial Microbes · 30.03.2026 · 17 (6) · 539-546

DOI: 10.1163/18762891-bja00115 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Beneficial Microbes, erschienen am 30.03.2026. Verfasst von N Mohy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurosciences Research Center (NSRC), Imam Reza General Hospital, 48432Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Oxidative Stress, Probiotics, Biomarkers, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress is a significant contributor to neuronal damage in multiple sclerosis (MS), marked by an imbalance in reactive oxygen species and antioxidant defences. Probiotics may modulate oxidative stress and improve antioxidant levels. This double-blind, randomised, placebo-controlled clinical trial aimed to evaluate the effects of probiotics supplementation on serum oxidative stress markers and endogenous antioxidants in patients with relapsing-remitting MS (RRMS). Ninety RRMS patients with expanded disability status scale [EDSS] < 4 were randomised into two groups: a probiotics group (Lactocare®) and a placebo group, and received the interventions twice daily for four months. Serum levels of oxidative stress markers (malondialdehyde [MDA]), endogenous antioxidants (glutathione peroxidase [GPx] activity, superoxide dismutase [SOD], catalase activity [CAT], glutathione [GSH]), and total antioxidant capacity (TAC) were measured at baseline and post-treatment. Fifty-five patients, including 26 patients in the probiotic group and 29 patients in the placebo group, completed the study. Both groups showed significant within-group improvements in GPx activity, SOD, and GSH levels, as well as reductions in MDA levels ( ); however, no significant between-group differences were found for any markers ( ). TAC and CAT levels remained unchanged in both groups. Findings of this study did not support the evidence for antioxidant effects of probiotics supplementation in RRMS patients, and its effects on oxidative stress markers in RRMS patients are found to be comparable to placebo. Iranian Registry of Clinical Trials: IRCT20220713055465N2, registration date: 2023.5.9

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressProbioticsBiomarkersMultiple Sclerosis, Relapsing-RemittingHumansDouble-Blind MethodFemaleAdultAntioxidantsMaleDietary SupplementsSuperoxide DismutaseGlutathione PeroxidaseMalondialdehydeGlutathioneMiddle AgedCatalaseYoung Adult

Substanzen

BiomarkersAntioxidantsSuperoxide DismutaseGlutathione PeroxidaseMalondialdehydeGlutathioneCatalase

Autor:innen und Institutionen

  • Neurosciences Research Center (NSRC), Imam Reza General Hospital, 48432Tabriz University of Medical Sciences, Tabriz, Iran.
  • Research Center for Integrative Medicine in Aging, Aging Research Institute, 48432Tabriz University of Medical Sciences, Tabriz, Iran.
  • Stem Cell and Regenerative Medicine Institute, 48432Tabriz University of Medical Sciences, Tabriz, Iran.
  • Student Research Committee, 48432Tabriz University of Medical Sciences, Tabriz, Iran.
  • Research Center for Evidence-Based Medicine, Iranian EBM Center: A Joanna Briggs Institute Center of Excellence, 48432Tabriz University of Medical Sciences, Tabriz, Iran.
  • Tabriz USERN Office, Universal Scientific Education and Research Network (USERN), Tabriz, Iran.

ORCID-Profile: N Mohy, S Sanaie, S Rahnemayan, M Yousefi, M Talebi, A Naseri

Zitieren

APA

Mohy, N., Sanaie, S., Rahnemayan, S., Yousefi, M., Talebi, M., & Naseri, A. (2026). The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial. Beneficial Microbes, 17(6), 539-546. https://doi.org/10.1163/18762891-bja00115

Vancouver

Mohy N, Sanaie S, Rahnemayan S, Yousefi M, Talebi M, Naseri A. The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial. Beneficial Microbes. 2026;17(6):539-546. doi:10.1163/18762891-bja00115

BibTeX
@article{Mohy2026,
  author = {Mohy, N and Sanaie, S and Rahnemayan, S and Yousefi, M and Talebi, M and Naseri, A},
  title = {The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial},
  journal = {Beneficial Microbes},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {539--546},
  doi = {10.1163/18762891-bja00115}
}
Kostenlos starten →